Chemical Compound

Ambrisentan; BSF 208075; LU 208075; Letairis; Volibris; (alphaS)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-benzenepropanoic Acid; Benzenepropanoic acid, alpha-[(4,6-dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-, (S)-; (alphaS)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenylbenzenepropanoic acid; 3109.F; GSK 1325760; 4051.F

Name: Ambrisentan; BSF 208075; LU 208075; Letairis; Volibris; (alphaS)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-benzenepropanoic Acid; Benzenepropanoic acid, alpha-[(4,6-dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-, (S)-; (alphaS)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenylbenzenepropanoic acid; 3109.F; GSK 1325760; 4051.F
Brand: EASY CDMO
SKU: 6918493

CAS Registry Number 177036-94-1

返回搜索申请报价

Primary record

Ambrisentan; BSF 208075; LU 208075; Letairis; Volibris; (alphaS)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-benzenepropanoic Acid; Benzenepropanoic acid, alpha-[(4,6-dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-, (S)-; (alphaS)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenylbenzenepropanoic acid; 3109.F; GSK 1325760; 4051.F

库存: 897 克
纯度: 98.6 %
CAS: 177036-94-1

化合物标识与属性

CAS: 177036-94-1
PubChem CID: 6918493
SMILES: CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
Canonical SMILES: COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O

名称与同义词

Ambrisentan
Letairis
Volibris
177036-94-1
ambrisentanum
null
Pulmonext
Ambrisentan [INN]
Ambrisentan?
(S)-ambrisentan
(+)-ambrisentan
(-)-ambrisentan
Letairis (TN)
Volibris (TN)
HW6NV07QEC
AC1OCFHZ
UNII-HW6NV07QEC
Ambrisentan (Standard)
RefChem:56361
BSF-208075
(+)-(S)-Ambrisentan
Ambrisentan (JAN/INN)
AMBRISENTAN [MI]
AMBRISENTAN [JAN]
CHEMBL1111
LU-208075
DTXSID4046282
Ambrisentan [INN:BAN:JAN]
D0X5ZI
AMBRISENTAN [VANDF]
Gilead brand of ambrisentan
SCHEMBL3679
BSF 208075
A1D5J
AMBRISENTAN [MART.]
C22H22N2O4
MFCD09842330
AMBRISENTAN [WHO-DD]
AMBRISENTAN, (+)-
DTXCID2026282
cc-160
MLS006010218
GSK1325760A
AMBRISENTAN [EMA EPAR]
GSK-1325760A
BSF 208075;AMBRISENTAN
GTPL3951
LU 208075
orb1307867
Ambrisentan - Bio-X trade mark
GSK1325760
LU208075
CTK8B8152
AMBRISENTAN [ORANGE BOOK]
C02KX02
GSK-1325760
BSF208075
CHEBI:135949
OUJTZYPIHDYQMC-LJQANCHMSA-N
GLXC-04478
ZINC538627
EX-A3315
KS-00000FU3
(S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid
Tox21_111967
(S)-2-(4,6-Dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid
Ambrisentan, 98% - 25MG 25mg
ANW-59416
BDBM50146710
CA0131
EBC-26858
FD7219
GSK 1325760A
HY-13209R
NP3038
s2097
AKOS015994540
C22-H22-N2-O4
Tox21_111967_1
AC-9015
ACN-030051
CCG-268386
CID6918493
CS-0447
CS-O-00462
DB06403
DE-0223
FA17344
GSK 1325760
NCGC00160662-01
NCGC00160662-02
NCGC00346730-01
AJ-23403
BA164153
BC224510
HY-13209
SMR004701307
AB0009811
AB2000501
TC-148161
A2966
B2075
CAS-177036-94-1
SW219060-1
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid
(2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid
BSF 208075;LU 208075
J2.651.033C
A11291
D07077
K-5435
AB01566890_01
EN300-7368573
A812234
Q410789
Benzenepropanoic acid, alpha-[(4,6-dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-, (alphaS)-
BRD-K41185545-001-02-3
(+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid
(+)-(2S)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid
(?S)-?-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-?-methoxy-?-phenylbenzenepropanoic acid
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid
(s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic acid
2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid
2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid
2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid
(+)-(2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid
(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenyl-propanoic acid
(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid
(2S)-2-[(4,6-Dimethylpyrimidine-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid
(S)-2-(4,6-Dimethyl-2-pyrimidinyloxy)-3-methoxy-3,3-diphenylpropanoic acid
(S)-2-(4,6-Dimethyl-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid
(S)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenylbenzenepropionic acid
Ambrisentan2-(4,6-Dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid
Benzenepropanoic acid, .alpha.-[(4,6-dimethyl-2-pyrimidinyl)oxy]-.beta.-methoxy-.beta.-phe
Benzenepropanoic acid, |A-[(4,6-dimethyl-2-pyrimidinyl)oxy]-|A-methoxy-|A-phenyl-, (|AS)-
(alpha S)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenylbenzenepropanoic acid
658-059-9
Ambrisentan; BSF 208075; LU 208075; Letairis; Volibris; (alphaS)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-benzenepropanoic Acid; Benzenepropanoic acid, alpha-[(4,6-dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-, (S)-; (alphaS)-alpha-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenylbenzenepropanoic acid; 3109.F; GSK 1325760; 4051.F